Purdue Pharma L.P. - Product Pipeline Review - 2014

Published: Apr, 2014 | Pages: 35 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Purdue Pharma L.P. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Purdue Pharma L.P. - Product Pipeline Review - 2014', provides an overview of the Purdue Pharma L.P.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Purdue Pharma L.P.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Purdue Pharma L.P. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Purdue Pharma L.P.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Purdue Pharma L.P.'s pipeline products

Reasons to buy

- Evaluate Purdue Pharma L.P.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Purdue Pharma L.P. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Purdue Pharma L.P.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Purdue Pharma L.P. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Purdue Pharma L.P.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Purdue Pharma L.P. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Purdue Pharma L.P. Snapshot 5
Purdue Pharma L.P. Overview 5
Key Information 5
Key Facts 5
Purdue Pharma L.P. - Research and Development Overview 6
Key Therapeutic Areas 6
Purdue Pharma L.P. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Combination Treatment Modalities 10
Pipeline Products - Partnered Products 11
Partnered Products/Combination Treatment Modalities 12
Pipeline Products - Out-Licensed Products 13
Out-Licensed Products/Combination Treatment Modalities 14
Purdue Pharma L.P. - Pipeline Products Glance 15
Purdue Pharma L.P. - Late Stage Pipeline Products 15
Pre-Registration Products/Combination Treatment Modalities 15
Phase III Products/Combination Treatment Modalities 16
Purdue Pharma L.P. - Clinical Stage Pipeline Products 17
Phase II Products/Combination Treatment Modalities 17
Purdue Pharma L.P. - Drug Profiles 18
(oxycodone hydrochloride + naloxone hydrochloride) 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
hydrocodone bitartrate 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
oxycodone hydrochloride ER 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
PRC-062 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
V-116517 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Purdue Pharma L.P. - Pipeline Analysis 24
Purdue Pharma L.P. - Pipeline Products by Target 24
Purdue Pharma L.P. - Pipeline Products by Route of Administration 25
Purdue Pharma L.P. - Pipeline Products by Molecule Type 26
Purdue Pharma L.P. - Pipeline Products by Mechanism of Action 27
Purdue Pharma L.P. - Recent Pipeline Updates 28
Purdue Pharma L.P. - Dormant Projects 29
Purdue Pharma L.P. - Discontinued Pipeline Products 30
Discontinued Pipeline Product Profiles 30
licostinel 30
Purdue Pharma L.P. - Company Statement 31
Purdue Pharma L.P. - Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Purdue Pharma L.P. - Key Manufacturing Facilities 33
Appendix 34
Methodology 34
Coverage 34
Secondary Research 34
Primary Research 34
Expert Panel Validation 34
Contact Us 35
Disclaimer 35

List of Tables
Purdue Pharma L.P., Key Information 5
Purdue Pharma L.P., Key Facts 5
Purdue Pharma L.P. - Pipeline by Indication, 2014 7
Purdue Pharma L.P. - Pipeline by Stage of Development, 2014 8
Purdue Pharma L.P. - Monotherapy Products in Pipeline, 2014 9
Purdue Pharma L.P. - Combination Treatment Modalities in Pipeline, 2014 10
Purdue Pharma L.P. - Partnered Products in Pipeline, 2014 11
Purdue Pharma L.P. - Partnered Products/ Combination Treatment Modalities, 2014 12
Purdue Pharma L.P. - Out-Licensed Products in Pipeline, 2014 13
Purdue Pharma L.P. - Out-Licensed Products/ Combination Treatment Modalities, 2014 14
Purdue Pharma L.P. - Pre-Registration, 2014 15
Purdue Pharma L.P. - Phase III, 2014 16
Purdue Pharma L.P. - Phase II, 2014 17
Purdue Pharma L.P. - Pipeline by Target, 2014 24
Purdue Pharma L.P. - Pipeline by Route of Administration, 2014 25
Purdue Pharma L.P. - Pipeline by Molecule Type, 2014 26
Purdue Pharma L.P. - Pipeline Products by Mechanism of Action, 2014 27
Purdue Pharma L.P. - Recent Pipeline Updates, 2014 28
Purdue Pharma L.P. - Dormant Developmental Projects,2014 29
Purdue Pharma L.P. - Discontinued Pipeline Products, 2014 30
Purdue Pharma L.P., Other Locations 32
Purdue Pharma L.P., Key Manufacturing Facilities 33